Oncology

Latest News

Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap
Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap

August 21st 2025

RIsing costs for therapies and inequities in reimbursement for genomic testing have created financial barriers for patients, according to appearing experts in Detroit, Michigan, on July 10, 2025.

The investigators found that tumor mutational burden and PD-L1 expression, which have traditionally been used as indicators of immunotherapy efficacy, had little predictive value for survival in this cohort. | Image credit: Dragana Gordic - stock.adobe.com
Predictive Model Forecasts Advanced NSCLC Outcomes

August 14th 2025

Dordaviprone is indicated for recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children. | Image credit: wladimir1804 - stock.adobe.com
FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma

August 6th 2025

Gen Li, PhD, MBA, president and founder of Phesi
Real-World Data, Digital Patient Profiles Are Revolutionizing Trial Design, Patient Recruitment: Gen Li, PhD, MBA

August 4th 2025

Value-based care. | Image Credit: irissca - stock.adobe.com
Legal Navigation Services Key to Addressing Disparities in Cancer Care

July 31st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
August 23rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 23rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Jeremy Bender, PhD | Image credit: Day One Biopharmaceuticals
April 25th 2024

Day One Marks Milestone in Pediatric Cancer as Tovorafenib Approved in BRAF-Mutated Low-Grade Glioma

Mary Caffrey
doctor consulting a patient in meeting in hospital for healthcare feedback or support-Happy medical or nurse with a mature person talking or speaking of test results or advice | Talia Mdlungu-peopleimages - stock.adobe.com
April 23rd 2024

Implementing Treatment Escalation Plans in Oncology Care at Admission Boosts Uptake, Study Finds

Pearl Steinzor
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
April 22nd 2024

Shawn Tuma Discusses the Dangers, Impacts of a Cyberattack on Health Care Systems

Maggie L. Shaw Pearl Steinzor
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP, highlights the biggest threats concerning a cyberattack on oncology practices.
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
April 18th 2024

Judith Alberto: COA Takes on Congress, Addresses Change Healthcare Cyberattack

Maggie L. Shaw Pearl Steinzor
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives at the Community Oncology Alliance (COA), discusses upcoming policy initiatives and the current oncology landscape amid a health care cyberattack.
Man being scanned by doctor | auremar - stock.adobe.com
April 18th 2024

Reducing Unnecessary Biopsies, Overdiagnosis in Prostate Cancer Screening

Pearl Steinzor
Integration of prostate MRI may improve the balance of patient harms and benefits in prostate cancer screening.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
April 17th 2024

Dr Mila Felder Shares Targeted Education Approaches to Promote Well-Being

Hayden E. Klein Pearl Steinzor
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, highlights strategic approaches for incorporating well-being into a postpandemic oncology workforce.
CHEA logo | Image: AJMC
April 16th 2024

Center on Health Equity and Access: April 2024

Hayden E. Klein Giuliana Grossi Rose McNulty Mary Caffrey
Will Shapiro, vice president of data science, Flatiron Health
April 15th 2024

Will Shapiro Shares How Artificial Intelligence Is Benefiting Oncology Care

Hayden E. Klein Pearl Steinzor
Will Shapiro, vice president of data science at Flatiron Health, discusses how the practice is using large language models (LLMs) to increase efficiency, while ensuring there are frameworks set for safety and quality.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
April 11th 2024

Dr Mila Felder Explains the Benefits of a Well-Being Council in Oncology Practices

Hayden E. Klein Pearl Steinzor
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, shares the importance of incorporating a culture of well-being within oncology practices.
cancer cells | Sodapeaw - stock.adobe.com
April 8th 2024

Accelerated Aging Linked to Increased Cancer Risk in Young Adults

Pearl Steinzor
Accelerated biological aging may be behind why some types of cancer are on the rise in young adults, researchers find.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
April 8th 2024

Dr Mila Felder Discusses How Peer Support Programs Can Help Alleviate Drug Shortage Distress

Hayden E. Klein Pearl Steinzor
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, shares insights on how peer support groups can help manage psychological and emotional distress amid a national drug shortage.
Red FDA approval stamp | Image credit: chrisdorney - stock.adobe.com
April 5th 2024

Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors

Mary Caffrey Laura Joszt, MA
FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Will Shapiro, vice president of data science, Flatiron Health
April 5th 2024

Will Shapiro Discusses Ethical Challenges Across Various Artificial Intelligence Models in Oncology

Hayden E. Klein Pearl Steinzor
Will Shapiro, vice president of data science at Flatiron Health, explains the different ethical challenges associated with various forms of artificial intelligence models used in oncology care.
Jonathan E. Levitt, Esq, Frier Levitt, LLC
April 5th 2024

Jon Levitt Highlights Urgency for Stronger Employer Oversight of PBMs

Maggie L. Shaw Mary Caffrey
Jonathan E. Levitt, Esq, founding partner of boutique health care law firm Frier Levitt, LLC, discusses a recent class-action lawsuit brought against Johnson & Johnson in which an employee alleged a breach of fiduciary duty regarding her employer-sponsored pharmacy benefits.
AJMC
April 5th 2024

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Ravi B. Parikh, MD, MPP Yasin Civelek, PhD, MS Pelin Ozluk, PhD David Debono, MD Michael J. Fisch, MD, MPH Gosia Sylwestrzak, MA Justin E. Bekelman, MD Aaron L. Schwartz, MD, PhD
Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.
Judy Alberto, MHA, RPh, BCOP, Community Oncology Alliance
April 5th 2024

Optimizing Formulary Management: COA's Judy Alberto Shares Insights

Maggie L. Shaw
Judy Alberto, MHA, RPh, BCOP, director of clinical initiatives at the Community Oncology Alliance (COA), addresses the challenges pharmacies face in managing formularies to provide optimal patient care.
COA 2024 | Image credit: COA
April 4th 2024

Navigating the Community Oncology Relationship With the Local Hospital

Mary Caffrey
A lawsuit that followed a health system revoking community oncologists' hospital privileges was the jumping off point for a discussion of how to manage this key relationship.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
April 4th 2024

Dr Mila Felder Discusses Peer-to-Peer Support in Health Care Organizations

Hayden E. Klein Pearl Steinzor
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, discusses the impact of peer support groups within a health care organization and its patients.
Emily Touloukian, DO, Coastal Cancer Center
April 1st 2024

2024 COA Community Oncology Conference Preview With Dr Emily Touloukian

Maggie L. Shaw
With the 2024 Community Oncology Conference, from the Community Oncology Alliance (COA), set to kick off this week in Orlando, Florida, The American Journal of Managed Care® spoke with Emily Touloukian, DO, COA board member and 1 of 6 cochairs for this year’s meeting, on highlights from the packed agenda and the power of advocacy.
Will Shapiro
March 28th 2024

Will Shapiro Discusses the Impact of Large Language Models on Cancer Care

Hayden E. Klein Pearl Steinzor
Will Shapiro, vice president of data science at Flatiron Health, discusses opportunities to implement artificial intelligence in cancer care.
Physician holds hand of patient | C Davids/peopleimages.com - stock.adobe.com
March 28th 2024

Oncologists Find Ethical Challenges With Artificial Intelligence in Cancer Care

Pearl Steinzor
Explainability, consent, and responsibility are noted as challenges that may hinder implementation of artificial intelligence (AI) in cancer care, according to a new study.
Woman with magnifying glass showing mole and birthmark on her body for prevention of melanoma | Peakstock - stock.adobe.com
March 19th 2024

Skin Cancer Incidence Highest Among Rural, SOC Individuals

Pearl Steinzor
Posters presented at the American Academy of Dermatology 2024 Annual Meeting identified significant health disparities among patients living in rural areas and those with skin of color (SOC).
FDA approved| Image credit: wladimir1804 - stock.adobe.com
March 15th 2024

FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy

Kristi Rosa
The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Help support advice guidance signpost | Image Credit: PX Media - stock.adobe.com
March 12th 2024

Navigating the Mental Health Challenges of Cancer Diagnosis, Treatment, and Survivorship

Maggie L. Shaw
Stress has potential links to worse outcomes in cancer, such as decreased quality of life and greater risks of disease progression and metastasis. There is a complex mix of emotions patients with cancer experience.
Breast cancer with lymphatics - Axel Kock - stock.adobe.com.jpeg
March 5th 2024

Annual Breast Cancer Screening Should Begin at Age 40 Years, Study Finds

Pearl Steinzor
Modeling estimates indicate that annual breast cancer screening starting at age 40 years provides the greatest benefit to women and reduces risk per examination.
Doctor comforting a patient | Image credit: lenetsnikolai - stock.adobe.com
March 1st 2024

Treating the Whole Person in Cancer Care: Addressing Comprehensive Services

Mary Caffrey
The session at ACCC's 50th Annual Meeting & Cancer Center Business Summit featured discussions on patient navigation, addressing patients' sexual health, needs of LGBTQ+ patients, and more.
Mila Felder, MD, FACEP
March 1st 2024

Dr Mila Felder Explains Advocate Health's Approach to Well-Being for the Postpandemic Oncology Workforce

Hayden E. Klein
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, talks about tailoring the Stanford Model of Professional Fulfillment to support the postpandemic oncology workforce.
Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients
March 1st 2024

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Margaret I. Liang, MD, MS Ling Chen, MD, MPH Emeline M. Aviki, MD, MBA Jason D. Wright, MD
Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.
New ONCare Alliance logo | Image Credit: ONCare Alliance
February 29th 2024

QCCA, NCCA Merge to Form ONCare Among Independent Oncology Practices

Mary Caffrey
ONCare Alliance will be led by 2 of the leading women in community oncology, cochairs Barbara McAneny, MD, of the New Mexico Cancer Center, and Sibel Blau, MD, of Northwest Medical Specialties, PLLC, of Puyallup, Washington.
ACCC logo | Image credit: ACCC
February 29th 2024

What Are the Steps to Quality Improvement in Cancer Care?

Mary Caffrey
Quality Improvement (QI) projects require a series of distinct steps and timely data collection that will allow clinics to see if changes are yielding results, a consultant told attendees at a preconference workshop at ACCC.
<1
...
789101112131415
...
187>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo